A pilot phase II study of peglylated liposomal doxorubicin (Doxil) with rituximab in relapsed AIDS-related non-Hodgkin's lymphomas
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2014
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Rituximab (Primary)
- Indications Burkitt's lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 23 Jun 2009 Additional lead trial investigator Anil Tulpule identified as reported by ClinicalTrials.gov.
- 22 Oct 2005 New trial record.